X4 Pharmaceuticals

XFOR

3.9402.34% ( +0.090 )

Closed: Jul 27, 16:00:00 (EDT)

Q1 FY2026 Earnings

Financial report interval: 2025.12.31 - 2026.03.31

Preview: X4 Pharmaceuticals(XFOR) predict that the Revenue is 2.708 M (-90.6%), Miss estimate;the EBIT is -20.31 M (-115%), Beat estimate;the EPS is -0.16 (-500%), Beat estimate.

Actual

YoY

Estimate

YoY

Vs estimate

YoY

RevenueMiss expectations

0.00B90.60%

0.00B88.89%

-0.00B1.71%

EBITExceed expectations

-0.02B115.04%

-0.03B165.45%

+0.00B50.41%

EPSExceed expectations

-0.16500.00%

-0.2600.00%

+0.0400100.00%

Revenue

ActualEstimateUnit: USD

EBIT

ActualEstimateUnit: USD

Net income

ActualEstimateUnit: USD

EPS

ActualEstimateUnit: USD